ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

HOWL Werewolf Therapeutics Inc

6.20
-0.01 (-0.16%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 82,150
Bid Price 6.00
Ask Price 7.09
News -
Day High 6.78

Low
1.5735

52 Week Range

High
8.1939

Day Low 6.10
Share Name Share Symbol Market Stock Type
Werewolf Therapeutics Inc HOWL NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.01 -0.16% 6.20 19:00:00
Open Price Low Price High Price Close Price Previous Close
6.22 6.10 6.78 6.75 6.21
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
1,656 82,150 US$ 6.55 US$ 537,946 - 1.5735 - 8.1939
Last Trade Type Quantity Price Currency
18:51:51 formt 150 US$ 6.20 USD

Werewolf Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
288.05M 42.74M - 19.94M -37.37M -0.87 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Werewolf Therapeutics News

Date Time Source News Article
4/24/202409:05GlobeNewswire Inc.Werewolf Therapeutics Announces WTX-124 Clinical Abstract..
4/23/202407:00GlobeNewswire Inc.Werewolf Therapeutics Presents First Preclinical Data..
4/05/202415:30GlobeNewswire Inc.Werewolf Therapeutics Presents Preclinical Results..
4/04/202415:30GlobeNewswire Inc.Werewolf Therapeutics to Present First-of-Its-Kind Data..
3/07/202406:22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee..
3/07/202406:15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/07/202406:11Edgar (US Regulatory)Form 8-K - Current report
3/07/202406:00GlobeNewswire Inc.Werewolf Therapeutics Reports Fourth Quarter and Full Year..
3/06/202407:00GlobeNewswire Inc.Werewolf Therapeutics to Present at the 2024 Leerink..
3/05/202415:30GlobeNewswire Inc.Werewolf Therapeutics Announces Upcoming Presentations at..
2/09/202415:39Edgar (US Regulatory)Form 8-K - Current report
2/09/202415:35Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No HOWL Message Board. Create One! See More Posts on HOWL Message Board See More Message Board Posts

Historical HOWL Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week5.796.785.626.25183,3290.417.08%
1 Month6.546.784.505.69195,441-0.34-5.20%
3 Months4.758.19394.506.20201,4391.4530.53%
6 Months2.408.19391.903.73597,1463.80158.33%
1 Year2.368.19391.57353.64328,2643.84162.71%
3 Years18.2123.991.395.29219,535-12.01-65.95%
5 Years18.2123.991.395.29219,535-12.01-65.95%

Werewolf Therapeutics Description

Werewolf Therapeutics Inc is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer.

Your Recent History

Delayed Upgrade Clock